In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Cabozantinib is an important targeted therapy drug, and its price dynamics have ···【more】
Release date:2025-02-12Recommended:297
As a multi-targeted tyrosine kinase inhibitor, cabozantinib has shown broad appl···【more】
Release date:2025-02-11Recommended:318
The interaction of avatrombopag with other drugs in clinical application has att···【more】
Release date:2025-02-11Recommended:230
Avatrombopag is a thrombopoietic drug that is widely used in the treatment of th···【more】
Release date:2025-02-10Recommended:264
Avatrombopag is a novel thrombopoietin receptor agonist, which has attracted muc···【more】
Release date:2025-02-10Recommended:257
Avatrombopag, as a thrombopoietin receptor agonist, plays an important role in t···【more】
Release date:2025-02-07Recommended:320
Avatrombopag is an important platelet-stimulating drug, and special care should ···【more】
Release date:2025-02-07Recommended:391
Avatrombopag is an innovative drug that has shown significant results in the tre···【more】
Release date:2025-02-06Recommended:271
Avatrombopag is a novel thrombopoietin receptor agonist, and its safety and side···【more】
Release date:2025-02-06Recommended:289
Avatrombopag is a drug used to treat thrombocytopenia, but its side effects are ···【more】
Release date:2025-02-05Recommended:265
Avatrombopag is a drug used to treat thrombocytopenia, but its use may be accomp···【more】
Release date:2025-02-05Recommended:249
Avatrombopag is a novel thrombopoietin receptor agonist, and its therapeutic eff···【more】
Release date:2025-01-22Recommended:271